CAS: 1150701-66-8
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GSK1940029 REF: TM-T5427CAS: 1150701-66-8 | 98.72% - 99.48% | 35,00 €~458,00 € | Mar 21 Ene 25 |
 | GSK1940029 REF: 3D-AWB70166CAS: 1150701-66-8 | Min. 95% | A consultar | Mar 18 Feb 25 |
 | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide REF: IN-DA008TPICAS: 1150701-66-8 | 98% | - - - | Producto descatalogado |
GSK1940029
CAS:1150701-66-8
GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD) inhibitor.
Fórmula:
C18H16Cl2N4O2
Pureza:
98.72% - 99.48%
Forma y color:
Solid
Peso molecular:
391.25
Ref: TM-T5427
| 1mg | 35,00 € | ||
| 5mg | 69,00 € | ||
| 10mg | 95,00 € | ||
| 25mg | 184,00 € | ||
| 50mg | 308,00 € | ||
| 100mg | 458,00 € | ||
| 1mL*10mM (DMSO) | 73,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
GSK1940029
CAS:1150701-66-8
GSK1940029 is a novel anti-inflammatory drug with a potency of about 150 times that of …
Fórmula:
C18H16Cl2N4O2
Pureza:
Min. 95%
Peso molecular:
391.25 g/mol
Ref: 3D-AWB70166
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
![1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide](https://static.cymitquimica.com/products/IN/thumb/DA008TPI.jpg)
1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide
CAS:1150701-66-8
Fórmula:
C18H16Cl2N4O2
Pureza:
98%
Peso molecular:
391.2512
Ref: IN-DA008TPI
| 1g | Descatalogado | Solicitar información | |
| 1mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información | |
| 250mg | Descatalogado | Solicitar información |
